Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CTSK | P43235 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | DRD2 | P14416 | 3/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.33 |
| ▸ | RELA | Q04206 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31250954 | 0.88 | CYP1A2 (0.36) | CTSKGAAMAOAMAOBHRH3 | |
| SCHEMBL25235574 | 0.84 | CTSK (0.36) | CA2CTSKGAAMAOAMAOB | |
| SCHEMBL25529790 | 0.84 | CTSK (0.36) | CA2CTSKGAAMAOAMAOB | |
| SCHEMBL24037096 | 0.84 | CTSK (0.36) | CA2CTSKGAAMAOAMAOB | |
| SCHEMBL31250609 | 0.81 | CTSK (0.37) | CA2CA12CA14CTSKTSHR | |
| SCHEMBL31250919 | 0.79 | MEN1 (0.40) | CA2CTSKTSHRDRD2CA1 | |
| SCHEMBL31250880 | 0.79 | CTSK (0.51) | CA2CTSKDRD2CA1SMN1; SMN2 | |
| SCHEMBL7578857 | 0.78 | KCNA3 (0.52) | CA2CTSKDRD2CA1SMN1; SMN2 | |
| SCHEMBL31250987 | 0.78 | KCNA3 (0.40) | CA2CTSKDRD2KDM1ACA1 | |
| SCHEMBL21063404 | 0.77 | CTSK (0.48) | CA2CA12CA14CTSKGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720058-A2 | BIFUNCTIONAL DEGRADERS AND USES THEREOF | Casma Therapeutics, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| WO-2024249291-A2 | BIFUNCTIONAL DEGRADERS AND USES THEREOF | CASMA THERAPEUTICS, INC. (US) | 2024-12-05 | — | — | WO | disclosed |